⌘K
Loading ticker…
As of 2026-09-10, Lifecore Biomedical, Inc. Common Stock (LFCR) has a 3-month relative strength percentile of 15 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 15.8 (Defensive). Sector: Healthcare, ranked 3 of 11. Average daily range 5.5%, relative volume 1.50×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
LFCR is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -10.9% / -30.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
LFCR is held by 6 ETFs as of Jun 2026. Top owner: VTI at 0.00% weight, $4M notional. Top 3 carry $10M.
Held by 23 ETFs · $13M across latest filings · largest weight 0.03% (IWC).
Top 6 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $4M | — |
| IWMiShares Russell 2000 ETF | 0.00% | $4M | — |
| VXFVanguard Extended Market ETF | 0.00% | $2M | — |
| IWNiShares Russell 2000 Value ETF | 0.01% | $1M | — |
| IWC | 0.03% | $498K | −0.01 pp |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $148K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LFCR Jan avg: -3.12% median: 0.66% win: 50% σ: 12.24% n: 4 2022-11-16 → 2026-08-31 | LFCR Feb avg: 0.57% median: -4.22% win: 25% σ: 19.30% n: 4 2022-11-16 → 2026-08-31 | LFCR Mar avg: -24.75% median: -35.60% win: 25% σ: 30.80% n: 4 2022-11-16 → 2026-08-31 | LFCR Apr avg: 16.45% median: 16.74% win: 75% σ: 16.79% n: 4 2022-11-16 → 2026-08-31 | LFCR May avg: 20.71% median: -0.42% win: 50% σ: 48.17% n: 4 2022-11-16 → 2026-08-31 | LFCR Jun avg: 7.61% median: 11.33% win: 75% σ: 14.85% n: 4 2022-11-16 → 2026-08-31 | LFCR Jul avg: 0.49% median: -2.81% win: 50% σ: 18.74% n: 4 2022-11-16 → 2026-08-31 | LFCR Aug avg: -11.18% median: -11.31% win: 50% σ: 18.97% n: 4 2022-11-16 → 2026-08-31 | LFCR Sep avg: 1.20% median: -3.28% win: 33% σ: 9.91% n: 3 2022-11-16 → 2026-08-31 (current) | LFCR Oct avg: 1.98% median: -2.31% win: 33% σ: 11.69% n: 3 2022-11-16 → 2026-08-31 | LFCR Nov avg: 8.72% median: 6.01% win: 75% σ: 16.16% n: 4 2022-11-16 → 2026-08-31 | LFCR Dec avg: -8.43% median: -6.70% win: 50% σ: 12.71% n: 4 2022-11-16 → 2026-08-31 |